Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma

We investigated whether the outcome prediction of patients with aggressive B-cell lymphoma can be improved by combining clinical, molecular genotype, and radiomics features. MYC, BCL2, and BCL6 rearrangements were assessed using fluorescence in situ hybridization. Seventeen radiomics features were e...

Descripción completa

Detalles Bibliográficos
Autores principales: Eertink, Jakoba J., Zwezerijnen, Gerben J. C., Wiegers, Sanne E., Pieplenbosch, Simone, Chamuleau, Martine E. D., Lugtenburg, Pieternella J., de Jong, Daphne, Ylstra, Bauke, Mendeville, Matias, Dührsen, Ulrich, Hanoun, Christine, Hüttmann, Andreas, Richter, Julia, Klapper, Wolfram, Jauw, Yvonne W. S., Hoekstra, Otto S., de Vet, Henrica C. W., Boellaard, Ronald, Zijlstra, Josée M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841040/
https://www.ncbi.nlm.nih.gov/pubmed/36306337
http://dx.doi.org/10.1182/bloodadvances.2022008629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841040/
https://www.ncbi.nlm.nih.gov/pubmed/36306337
http://dx.doi.org/10.1182/bloodadvances.2022008629

Ejemplares similares